community download

Whitepaper: A look into Multiple Sclerosis

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Multiple Sclerosis (MS) is a progressive and chronic disease that attacks the central nervous system. It occurs when the body's own immune system attack the protective sheath (myelin) around the nerve fibres (axons) in the brain and spinal cord, resulting in random patches called plaques or lesions. These in turn distort and interrupt their ability to conduct signals. The disease derives its name from ‘Sclerosis’ meaning scars and ‘multiple’ because the damage usually occurs across a number of points.

More than 2.5 million people around the world are said to be affected by multiple sclerosis. Disease onset is usually seen more in young adults, and it is more common in women. Almost 98% of the MS population is Caucasian. MS is generally more common in people living in temperate zones.

Download the Whitepaper provided by Genpharm by filling in the form to your right.

Thanks,
World Orphan Drug Congress team